Sign in
4

Changes in Ownership

REVELATION BIOSCIENCES, INC. Filed Acc 0001193125-25-260417

Chief Financial Officer acquired 390,614 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Zygmont Chester Stanley III Chief Financial Officer 2025-10-29 Grant or award +390,614 $1.28 $499,986 395,645 I
Loading xslF345X05/ownership.xml…